Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary

Arch Dermatol. 2000 Aug;136(8):1044-9. doi: 10.1001/archderm.136.8.1044.

Author

R D Sontheimer¹

Affiliation

¹ Department of Dermatology, The University of Iowa College of Medicine/The University of Iowa Health Care, Iowa City, IA 52242-1090, USA. richard-sontheimer@uiowa.edu

PMID: 10926741
DOI: 10.1001/archderm.136.8.1044

No abstract available

Publication types

Comment
Editorial
Review

MeSH terms

Antimalarials / adverse effects*
Delivery of Health Care
Hematologic Tests / economics
Humans
Hydroxychloroquine / adverse effects*
Lupus Erythematosus, Cutaneous / drug therapy*
United States

Substances

Antimalarials
Hydroxychloroquine